CM
DGX icon

Churchill Management’s Quest Diagnostics DGX Stock Holding History

Churchill Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$16M Buy
88,809
+393
+0.4% +$68.3K 0.17% 46
2025
Q1 		$15M Buy
+88,416
New +$14.5M 0.19% 41
2024
Q1 		– Sell
-10,758
Closed -$1.48M – 154
2023
Q4 		$1.48M Buy
+10,758
New +$1.41M 0.02% 121
2021
Q1 		– Sell
-19,196
Closed -$2.29M – 138
2020
Q4 		$2.29M Sell
19,196
-2,108
-10% -$257K 0.04% 125
2020
Q3 		$2.44M Sell
21,304
-2,526
-11% -$298K 0.06% 111
2020
Q2 		$2.72M Buy
+23,830
New +$2.53M 0.08% 87

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Churchill Management's DGX Position: Q2 2025 in Review

Churchill Management increased its Quest Diagnostics (DGX) stake by 0.44% in Q2 2025, buying an estimated $68.3K and bringing the position to 88,809 shares worth $16M. The position accounts for 0.17% of the portfolio, ranked #46.

Churchill Management first reported a position in DGX in Q2 2020 and has held it in 6 quarters since. 990 funds tracked by Wall St. Rank hold DGX as of Q2 2025.

  • Churchill Management held 88,809 shares of Quest Diagnostics worth $16M as of Q2 2025.
  • Churchill Management bought 393 Quest Diagnostics shares in Q2 2025, an estimated $68.3K.
  • Quest Diagnostics made up 0.17% of Churchill Management's portfolio in Q2 2025, its #46 holding.
  • Churchill Management first reported a position in Quest Diagnostics in Q2 2020 and has held it in 6 quarters since.
  • 990 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.

Based on Churchill Management's 13F filing for Q2 2025, filed 18 Jul 2025.